Diamond Therapeutics
www.diamondthera.comThe promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments. Our first clinical program is focused on accessible psilocybin-based drugs that deliver rapid therapeutic outcomes without perceptual side effects. By eliminating the side effects, this intervention can be administered to a broad cohort of patients.
Read moreThe promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it. We're developing safe, FDA, EMA and Health Canada approved therapies for neuropsychiatric conditions, starting with sub-perceptual psilocybin-based medicines that have the potential to deliver greater impact than current first-line treatments. Our first clinical program is focused on accessible psilocybin-based drugs that deliver rapid therapeutic outcomes without perceptual side effects. By eliminating the side effects, this intervention can be administered to a broad cohort of patients.
Read moreCountry
City (Headquarters)
Toronto
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
- Vice President , Pharmaceutical DevelopmentEmail ****** @****.comPhone (***) ****-****
- Small Business OwnerEmail ****** @****.comPhone (***) ****-****
- Founder and Chief Executive OfficerEmail ****** @****.comPhone (***) ****-****
- Chief Financial OfficerEmail ****** @****.comPhone (***) ****-****
Technologies
(7)
